首页|基于三焦膜腠理论探析卵巢癌的病机与辨治

基于三焦膜腠理论探析卵巢癌的病机与辨治

扫码查看
基于"三焦膜腠"理论,认为卵巢癌起源于三焦膜腠,并可由三焦膜腠转移他处,其病位居于下焦,以元阳不足、三焦膜腠气机不利导致三焦膜腠功能失常为关键病机.治疗主张病证结合,标本同治,重在调理三焦膜腠功能,通过温阳益气、行气活血、祛瘀化痰、解毒散结等法使三焦膜腠通畅,并以此为指导拟定益气活血解毒方作为治疗卵巢癌的基本方.同时,注重分期论治,急病阶段辅助西医治疗,减毒增效,减少不良反应;疾病缓解或稳定阶段,以及晚期姑息性治疗阶段,则根据患者的体质状态及中医证候特点予个体化加减药物,以改善肿瘤微环境.
Analysing the Pathogenesis and Treatment of Ovarian Cancer Based on the Theory of"Sanjiao Membrane and Interstice"
Based on the theory of"sanjiao membrane and interstice",it is believed that ovarian cancer originates from sanjiao membrane and interstice,and can be transferred to other places from sanjiao membrane and interstice,and the disease is located in the lower jiao,with key pathogenesis as the malfunction of sanjiao membrane and inter-stice caused by original yang deficiency and disturbance of qi movement in sanjiao membrane and interstice.The treatment advocates combining disease and syndrome,treating the root and branch simultaneously,focusing on regu-lating the function of sanjiao membrane and interstice,making sanjiao membrane and interstice smooth by warming yang and benefiting qi,moving qi and activating blood circulation,eliminating blood stasis and removing phlegm,de-toxifying and dissipating masses,and so on,with Yiqi Huoxue Jiedu Formula(益气活血解毒方)as a basic formula for treating ovarian cancer.Meanwhile,focusing on the staging of treatment,western medicine treatment can be assisted in the acute stage to reduce the toxicity,increase the effect,and reduce the adverse reaction;in the remission or stabi-lisation stage,as well as in the advanced stage with palliative treatment,individualised addition and subtraction of medications can be given according to the patient's physical condition and the characteristics of traditional Chinese medicine syndrome,so as to improve the microenvironment of the tumour.

ovarian cancersanjiao membrane and intersticeoriginal yang deficiencydisturbance of qi movement

宋清雅、卢雯平

展开 >

中国中医科学院广安门医院,北京市西城区北线阁5号,100053

卵巢癌 三焦膜腠 元阳不足 气机不利

国家自然科学基金北京市自然科学基金国家中医药管理局中医药创新团队及人才支持计划

824743547212192ZYYCXTD-C-202205

2024

中医杂志
中华中医药学会 中国中医科学院

中医杂志

CSTPCD北大核心
影响因子:1.464
ISSN:1001-1668
年,卷(期):2024.65(20)